You are here

Orexigen

Orexigen’s Weight-Loss Roller Coaster to End With a Bankruptcy Sale

Xconomy

Mon, 03/12/18 - 09:47 am

Orexigen posts a ‘for sale’ sign in the yard as weak Contrave sales raise concerns

Endpoints

Tue, 10/17/17 - 09:50 am

Orexigen - Contrave Sales Present Troubling Data

Seeking Alpha

Tue, 06/21/16 - 11:21 am

Orexigen struggles to stay afloat as obesity market stagnates

BioPharma Dive

Thu, 05/19/16 - 09:43 am

Arena Investors: What To Consider As Anti-Obesity Drugs Fizzle

Seeking Alpha

Mon, 05/16/16 - 09:32 pm

Arena Pharmaceuticals

Orexigen Therapeutics posts 1st-quarter loss of $22.3 million

Yahoo/AP

Wed, 05/4/16 - 06:46 pm

Orexigen Pulls The Plug On Post-Marketing Cardiovascular Trial

Seeking Alpha

Sat, 04/16/16 - 04:27 pm

Orexigen: Contrave Sales Flatten Out At End Of Q1

Seeking Alpha

Mon, 04/11/16 - 09:58 am

Arena Pharmaceuticals

Orexigen buys U.S. obesity pill rights from Takeda, partners Valeant

Yahoo/Reuters

Tue, 03/15/16 - 09:32 am

Valeant Pharmaceuticals

Orexigen takes another body blow from ill-fated Contrave trial

Fierce Pharma

Wed, 03/9/16 - 03:40 pm

clinical trials

The Next 6 Months Are Critical For Orexigen

Seeking Alpha

Wed, 03/2/16 - 10:51 am

Hoping Vivus and Orexigen can finally kick-start their obesity meds? Don't count on it, analyst says

Fierce Pharma Marketing

Tue, 03/1/16 - 10:56 pm

Belviq Sales Close Out 2015 With A Slump

Seeking Alpha

Sat, 01/9/16 - 10:39 am

Arena Pharmaceuticals

Are Takeda's 900 Contrave reps worth it? Maybe not, analyst says

Fierce Pharma Marketing

Mon, 11/9/15 - 03:38 pm

10 Worst NASDAQ Biotech Stocks in the Third Quarter

TheStreet.com

Wed, 09/30/15 - 07:51 pm

Celldex Therapeutics

Arena Pharmaceuticals

Raptor Pharmaceutical

Contrave script growth snags, despite Takeda's 900-strong salesforce

Fierce Pharma Marketing

Tue, 09/29/15 - 09:16 am

Why Hasn't Orexigen Launched Its Obesity Drug in Europe Yet?

Motley Fool

Sat, 09/19/15 - 09:14 am

Orexigen Therapeutics reports second-quarter loss, misses expectations

Yahoo/AP

Thu, 08/6/15 - 10:20 am

Orexigen - Contrave Takes Sales Lead In The U.S. - More Sales Still Needed

Seeking Alpha

Mon, 06/22/15 - 12:49 pm

Arena Pharmaceuticals

Brutal honesty in drug marketing? For obesity meds, it's key to avoiding the 'magic pill' trap

Fierce Pharma Marketing

Mon, 06/8/15 - 12:13 pm

Arena Pharmaceuticals

Pages